← Back to directory

Antonio C. Wolff

Researcher Next ID · RN-021282

Researcher · Biochemistry, Genetics and Molecular Biology

University of Copenhagen

Copenhagen, Denmark

Not currently recruitingFunding unknown
Works count
917
Citation count
60,239
H-index
99
i10-index
311

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Breast Cancer Treatment Studies
HER2/EGFR in Cancer Research
Advanced Breast Cancer Therapies
Cancer Treatment and Pharmacology
Cancer Genomics and Diagnostics

Publications

  • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update

    Journal of Clinical Oncology · 2023 · 10.1200/jco.22.02864

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

    Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.19.02309

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

    Archives of Pathology & Laboratory Medicine · 2020 · https://doi.org/10.5858/arpa.2019-0904-sa

  • TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

    Journal of Clinical Oncology · 2020 · 10.1200/jco.20.02151

  • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

    Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2018.77.8738

  • Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

    New England Journal of Medicine · 2016 · 10.1056/nejmoa1604700

  • Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

    New England Journal of Medicine · 2015 · 10.1056/nejmoa1406281

  • Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

    Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2015.62.1797

  • Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

    Journal of Clinical Oncology · 2014 · 10.1200/jco.2013.55.0491

  • Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

    Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2013.50.9984

  • Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

    Journal of Clinical Oncology · 2012 · 10.1200/jco.2012.45.9859

  • TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

    Journal of Clinical Oncology · 2012 · 10.1200/jco.2010.34.5579

  • American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

    Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.25.6529

  • American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)

    Archives of Pathology & Laboratory Medicine · 2010 · https://doi.org/10.5858/134.7.e48

  • Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

    New England Journal of Medicine · 2009 · 10.1056/nejmoa0810266

  • Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

    New England Journal of Medicine · 2008 · 10.1056/nejmoa0707056

  • American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting

    Journal of Clinical Oncology · 2006 · 10.1200/jco.2006.08.8575

  • American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

    Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2006.09.2775

  • 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

    Journal of Clinical Oncology · 2006 · 10.1200/jco.2006.06.4451

  • American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

    Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.08.001

  • American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004

    Journal of Clinical Oncology · 2004 · 10.1200/jco.2005.09.121

Current projects

    No projects listed.